title: Endomorphins fully activate a cloned human mu opioid receptor.
abstract: Endomorphins were recently identified as endogenous ligands with high selectivity for mu opioid receptors. We have characterized the ability of endomorphins to bind to and functionally activate the cloned human mu opioid receptor. Both endomorphin-1 and endomorphin-2 exhibited binding selectivity for the mu opioid receptor over the delta and kappa opioid receptors. Both agonists inhibited forskolin-stimulated increase of cAMP in a dose-dependent fashion. When the mu opioid receptor was coexpressed in Xenopus oocytes with G protein-activated K+ channels, application of either endomorphin activated an inward K+ current. This activation was dose-dependent and blocked by naloxone. Both endomorphins acted as full agonists with efficacy similar to that of [D-Ala2,N-Me-Phe4,Gly-ol5]enkephalin (DAMGO). These data indicate that endomorphins act as full agonists at the human mu opioid receptor, capable of stimulating the receptor to inhibit the cAMP/adenylyl cyclase pathway and activate G-protein-activated inwardly rectifying potassium (GIRK) channels.
authors.affiliation: Department of Cell Biology, Neurobiology and Anatomy, University of Cincinnati College of Medicine, OH 45267-0521, USA.
authors.forename: J
authors.initials: J
authors.lastname: Gong
authors.forename: J A
authors.initials: JA
authors.lastname: Strong
authors.forename: S
authors.initials: S
authors.lastname: Zhang
authors.forename: X
authors.initials: X
authors.lastname: Yue
authors.forename: R N
authors.initials: RN
authors.lastname: DeHaven
authors.forename: J D
authors.initials: JD
authors.lastname: Daubert
authors.forename: J A
authors.initials: JA
authors.lastname: Cassel
authors.forename: G
authors.initials: G
authors.lastname: Yu
authors.forename: E
authors.initials: E
authors.lastname: Mansson
authors.forename: L
authors.initials: L
authors.lastname: Yu
mesh_terms: D000701:Analgesics, Opioid / Q000494:pharmacology*; D000818:Animals; D016466:CHO Cells; D005576:Colforsin / Q000494:pharmacology; D006224:Cricetinae; D000242:Cyclic AMP / Q000378:metabolism; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D004745:Enkephalins / Q000378:metabolism; D019204:GTP-Binding Proteins / Q000378:metabolism; D006801:Humans; D009842:Oligopeptides / Q000494:pharmacology*; D009865:Oocytes / Q000378:metabolism; D015221:Potassium Channels / Q000378:metabolism; D017450:Receptors, Opioid, mu / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D014162:Transfection; D014981:Xenopus
chemical_list: D000701:Analgesics, Opioid; D004745:Enkephalins; D009842:Oligopeptides; D015221:Potassium Channels; D017450:Receptors, Opioid, mu; D011994:Recombinant Proteins; C105293:endomorphin 1; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D005576:Colforsin; C105294:endomorphin 2; D000242:Cyclic AMP; D019204:GTP-Binding Proteins